BT-02
- Generic Name
- BT-02
Clinical Trial of BT02 in Patients With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Advanced Solid Tumor
- Interventions
- First Posted Date
- 2024-05-08
- Last Posted Date
- 2024-12-27
- Target Recruit Count
- 60
- Registration Number
- NCT06404905
- Locations
- 🇨🇳
Cancer Institute and Hospital, Beijing, Biejing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath